-transparent.png){kind=logo}
Ten patients who suffered from a primary depressive illness were treated with a new antidepressant drug butriptyline (150 mg/day). Six of the patients showed marked clinical improvement, as judged by depression rating scores, at the end of 22 days of treatment. No simple relationship was found between clinical response and plasma butriptyline concentration. Butriptyline is an effective antidepressant agent, well tolerated and with few side effects.
Related Publications
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
January 1971,
Journal of medicine,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
January 1971,
Journal of medicine,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
December 1969,
Archives internationales de pharmacodynamie et de therapie,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
September 1977,
Clinical pharmacology and therapeutics,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
September 2017,
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
January 1971,
Journal of medicine,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
July 1978,
Lancet (London, England),
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
May 1978,
Lancet (London, England),
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
November 1975,
Clinical pharmacology and therapeutics,
G D Burrows, and
T R Norman, and
K P Maguire, and
G Rubinstein, and
B A Scoggins, and
B Davies
May 1978,
The Journal of clinical psychiatry,
